Neovasc Inc.
(Toronto Stock Exchange : NVCN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.15%78.360.6%$440.98m
ABTAbbott Laboratories
0.59%56.330.8%$367.45m
BDXBecton, Dickinson and Company
1.19%211.861.3%$227.57m
TMOThermo Fisher Scientific Inc.
0.70%193.791.0%$225.78m
ISRGIntuitive Surgical, Inc.
3.39%369.582.5%$211.34m
ALGNAlign Technology, Inc.
2.03%200.856.3%$172.99m
DXCMDexCom, Inc.
-0.45%44.788.7%$162.60m
SYKStryker Corporation
0.78%150.481.3%$157.80m
XRAYDENTSPLY International Inc.
1.93%61.843.0%$134.96m
ZBHZimmer Biomet Holdings, Inc.
0.36%122.321.7%$133.04m
EWEdwards Lifesciences Corporation
1.05%113.211.2%$132.84m
BCRC. R. Bard, Inc.
0.51%328.981.6%$127.30m
BAXBaxter International Inc.
0.17%63.581.7%$127.26m
BSXBoston Scientific Corporation
0.44%29.701.1%$121.43m
COOCooper Companies, Inc.
-0.31%235.342.2%$118.57m

Company Profile

Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.